BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 25, Issue 19
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (19215)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.
Item 
Count 
PDF1569
WORD382
HTML12988
Figures (1-2)341
 Sum=15280
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse705
Download722
 Sum=1427
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse948
Download1560
 Sum=2508
May 21, 2019 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Ogunwobi OO, Harricharran T, Huaman J, Galuza A, Odumuwagun O, Tan Y, Ma GX, Nguyen MT. Mechanisms of hepatocellular carcinoma progression. World J Gastroenterol 2019; 25(19): 2279-2293 [PMID: 31148900 DOI: 10.3748/wjg.v25.i19.2279]
URL: https://www.wjgnet.com/1007-9327/full/v25/i19/2279.htm
Number Citing Articles
1
Lei Sun, Yaru Lin, Guichun Wang, Lin Zhang, Liangchang Hu, Zhong Lu. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer. Bioscience Reports 2021; 41(1) doi: 10.1042/BSR20203115
2
Yih-Fung Chen, Ho-Cheng Wu, Jia-Min Chang, Horng-Huey Ko, Chu-Hung Lin, Hsun-Shuo Chang. Chemical investigations and cytotoxic effects of metabolites from Antrodia camphorata against human hepatocellular carcinoma cells. Natural Product Research 2023; 37(4): 560 doi: 10.1080/14786419.2022.2076676
3
Xianwu Yang, Xiaojuan Tian, Pengcheng Zhao, Zheng Wang, Xuedong Sun. Paclitaxel inhibits hepatocellular carcinoma tumorigenesis by regulating the circ_0005785/miR‐640/GSK3β. Cell Biology International 2023; 47(7): 1170 doi: 10.1002/cbin.11906
4
Heena B Choudhary, Satish K Mandlik, Deepa S Mandlik. Role of p53 suppression in the pathogenesis of hepatocellular carcinoma. World Journal of Gastrointestinal Pathophysiology 2023; 14(3): 46-70 doi: 10.4291/wjgp.v14.i3.46
5
Marwa A. Abdel-Wahed, Eman Mohamed Abdel Rahman Amer, Ramy Mohamed Mahmoud, Iman Fawzy Montasser, Yassmin M. Massoud, Perihan Hamdy, Safeya Hamdy Zakaria Hassan. CTNNB1 polymorphism (rs121913407) in circulating tumor DNA (ctDNA) in Egyptian hepatocellular carcinoma patients. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00204-0
6
Urvashi Vijay, Pranathi Pappu, Dhatri Madduru, Ngalah Bidii Stephen, Prashanth Suravajhala, Obul Reddy Bandapalli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 293 doi: 10.1016/B978-0-323-98806-3.00008-8
7
Lok-Sze Wong, Chun-Ming Wong. Decoding the Roles of Long Noncoding RNAs in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(6): 3137 doi: 10.3390/ijms22063137
8
Shibambika Manna, Pragati Samal, Rohini Basak, Anushka Mitra, Arijit Kumar Roy, Raima Kundu, Amrita Ahir, Amlan Roychowdhury, Ditipriya Hazra. Amentoflavone and methyl hesperidin, novel lead molecules targeting epitranscriptomic modulator in acute myeloid leukemia: in silico drug screening and molecular dynamics simulation approach. Journal of Molecular Modeling 2023; 29(1) doi: 10.1007/s00894-022-05407-1
9
Jingjing Zhang, Xiaoxuan Ma, Daidi Fan. Ginsenoside CK Inhibits Hypoxia-Induced Epithelial–Mesenchymal Transformation through the HIF-1α/NF-κB Feedback Pathway in Hepatocellular Carcinoma. Foods 2021; 10(6): 1195 doi: 10.3390/foods10061195
10
Xiaowei Chang, Chang Tian, Yuanyuan Jia, Yu Cai, Pu Yan. MLXIPL promotes the migration, invasion, and glycolysis of hepatocellular carcinoma cells by phosphorylation of mTOR. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10652-5
11
Zhou-wei Xu, Na-na Liu, Xing-yu Wang, Bai-cheng Ding, Hai-feng Zhang, Ying Li, Wu-yi Sun, Wei Wei. Effect of PLC-β1/CaM signaling pathway mediated by AT1R on the occurrence and development of hepatocellular carcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02261-8
12
Liberatore Tramontano, Carlo Cavaliere, Marco Salvatore, Valentina Brancato. The Role of Non-Gaussian Models of Diffusion Weighted MRI in Hepatocellular Carcinoma: A Systematic Review. Journal of Clinical Medicine 2021; 10(12): 2641 doi: 10.3390/jcm10122641
13
Marwa Matboli, Gouda I. Diab, Maha Saad, Abdelrahman Khaled, Marian Roushdy, Marwa Ali, Hind A. ELsawi, Ibrahim H. Aboughaleb. Machine-Learning-Based Identification of Key Feature RNA-Signature Linked to Diagnosis of Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2024; 14(6): 101456 doi: 10.1016/j.jceh.2024.101456
14
Yang Yan, Xiao Shi Lin, Wang Zheng Ming, Zhang Qi Chuan, Gan Hui, Sun Ya Juan, Wang Shuang, LV Yang Fan, Zhang Dong. Radiomic Analysis Based on Gd-EOB-DTPA Enhanced MRI for the Preoperative Prediction of Ki-67 Expression in Hepatocellular Carcinoma. Academic Radiology 2024; 31(3): 859 doi: 10.1016/j.acra.2023.07.019
15
Rui Huang, Lijun Zhang, Jinmei Jin, Yudong Zhou, Hongwei Zhang, Chao Lv, Dong Lu, Ye Wu, Hong Zhang, Sanhong Liu, Hongzhuan Chen, Xin Luan, Weidong Zhang. Bruceine D inhibits HIF-1α-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/β-catenin interaction. Acta Pharmaceutica Sinica B 2021; 11(11): 3481 doi: 10.1016/j.apsb.2021.05.009
16
Juan Manuel Velázquez-Enríquez, Renata Cerna, Olga Beltrán-Ramírez, Carolina Piña-Vázquez, Saúl Villa-Treviño, Verónica Rocío Vásquez-Garzón. DCLK1 is Overexpressed and Associated with Immune Cell Infiltration in Hepatocellular Carcinoma. Biochemical Genetics 2024;  doi: 10.1007/s10528-024-10667-y
17
Weiwei Jiang, Yan Wang, Wanli He, Peng Wang, Peng Meng, Shanfeng Zhang. CircCOCH plays a critical role in Hepatocellular carcinoma through modulating miR-450a and activating PI3K/mTOR pathway. Translational Oncology 2024; 49: 102090 doi: 10.1016/j.tranon.2024.102090
18
Wuyu Chen, Minghao Ruan, Minghao Zou, Fuchen Liu, Hui Liu. Clinical Significance of Non-Coding RNA Regulation of Programmed Cell Death in Hepatocellular Carcinoma. Cancers 2023; 15(16): 4187 doi: 10.3390/cancers15164187
19
Zilong Yan, Qingen Da, Zhangfu Li, Qirui Lin, Jing Yi, Yanze Su, Guanyin Yu, Qingqi Ren, Xu Liu, Zewei Lin, Jianhua Qu, Weihua Yin, Jikui Liu. Inhibition of NEK7 Suppressed Hepatocellular Carcinoma Progression by Mediating Cancer Cell Pyroptosis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.812655
20
Keisuke Fukuchi, Kayoko Nanai, Hiroshi Yuita, Chikako Maru, Jun Tsukada, Masato Ishigami, Yoko Nagai, Yoko Nakano, Chigusa Yoshimura, Kozo Yoneda, Masato Amano, Kensuke Nakamura, Yoko Oda, Haruyuki Nishigohri, Shoji Yamamoto, Yusuke Ohnishi-Totoki, Koichiro Inaki, Hironobu Komori, Rika Nakano, Yoshiyuki Kanari, Atsuko Nishida, Yumi Matsui, Satoko Funo, Sayako Takahashi, Toshiaki Ohtsuka, Toshinori Agatsuma, Shuanglin Qin. Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/3552793
21
So Young Kim, Cheol Park, Min Yeong Kim, Seon Yeong Ji, Hyun Hwangbo, Hyesook Lee, Su Hyun Hong, Min Ho Han, Jin-Woo Jeong, Gi-Young Kim, Chang-Gue Son, JaeHun Cheong, Yung Hyun Choi. ROS-Mediated Anti-Tumor Effect of Coptidis Rhizoma against Human Hepatocellular Carcinoma Hep3B Cells and Xenografts. International Journal of Molecular Sciences 2021; 22(9): 4797 doi: 10.3390/ijms22094797
22
Arash Letafati, Sajad Najafi, Mehran Mottahedi, Mohammad Karimzadeh, Ali Shahini, Setareh Garousi, Mohammad Abbasi-Kolli, Javid Sadri Nahand, Seyed Saeed Tamehri Zadeh, Michael R. Hamblin, Neda Rahimian, Mohammad Taghizadieh, Hamed Mirzaei. MicroRNA let-7 and viral infections: focus on mechanisms of action. Cellular & Molecular Biology Letters 2022; 27(1) doi: 10.1186/s11658-022-00317-9
23
Wenqian Qi, Qian Zhang. Insights on epithelial cells at the single-cell level in hepatocellular carcinoma prognosis and response to chemotherapy. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1292831
24
Munetoshi Akaoka, Koichiro Haruki, Tomohiko Taniai, Mitsuru Yanagaki, Yosuke Igarashi, Kenei Furukawa, Shinji Onda, Masashi Tsunematsu, Yoshihiro Shirai, Norimitsu Okui, Takeshi Gocho, Toru Ikegami. Clinical significance of cachexia index in patients with hepatocellular carcinoma after hepatic resection. Surgical Oncology 2022; 45: 101881 doi: 10.1016/j.suronc.2022.101881
25
Apichaya Khlaiphuengsin, Natthaya Chuaypen, Pimpayao Sodsai, Supranee Buranapraditkun, Tadech Boonpiyathad, Nattiya Hirankarn, Pisit Tangkijvanich. Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(20): 2645-2656 doi: 10.3748/wjg.v26.i20.2645
26
Shijing Tang, Hao Chen. Prognostic Significance of Iron Metabolism and Immune-Related Genes as Risk Markers in Hepatocellular Carcinoma . Journal of Environmental Pathology, Toxicology and Oncology 2024; 43(3): 51 doi: 10.1615/JEnvironPatholToxicolOncol.2024050167
27
Saranya Chidambaranathan-Reghupaty, Paul B. Fisher, Devanand Sarkar. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 1 doi: 10.1016/bs.acr.2020.10.001
28
Meritxell Perramón, Wladimiro Jiménez. Pituitary Tumor-Transforming Gene 1/Delta like Non-Canonical Notch Ligand 1 Signaling in Chronic Liver Diseases. International Journal of Molecular Sciences 2022; 23(13): 6897 doi: 10.3390/ijms23136897
29
Francisco Villalba-López, Luis Francisco Sáenz-Mateos, Maria Isabel Sánchez-Lorencio, Virginia De La Orden-García, Felipe Alconchel-Gago, Pedro Antonio Cascales-Campos, Carmen García-Bernardo, José Antonio Noguera-Velasco, Alberto Baroja-Mazo, Pablo Ramírez-Romero. Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32879-9
30
Yue He, Wenqiang Tao, Chao Shang, Chan Qi, Dexiang Ji, Wei Lu, Guoan Chen. Xeroderma Pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPARγ pathway. International Journal of Experimental Pathology 2021; 102(3): 157 doi: 10.1111/iep.12396
31
An Li, Ning Wu, Jingyu Sun. E2F1‑induced microRNA‑224‑5p expression is associated with hepatocellular carcinoma cell migration, invasion and epithelial‑mesenchymal transition via MREG. Oncology Letters 2022; 23(3) doi: 10.3892/ol.2022.13202
32
Ashwaq Alolyan, Kanan Alshammari, Mohammad Arabi, Ahmed Alshehri, Hamad Alsuhaibani, Fahad Ibnshamsah, Abdullah Alsharm, Mervat Mahrous, Adnan Al Zanbagi, Mazen Hassanain, Shouki Bazarbashi. Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia. Journal of Hepatocellular Carcinoma 2024; : 349 doi: 10.2147/JHC.S442842
33
Bufu Tang, Jinyu Zhu, Zhongwei Zhao, Chenying Lu, Siyu Liu, Shiji Fang, Liyun Zheng, Nannan Zhang, Minjiang Chen, Min Xu, Risheng Yu, Jiansong Ji. Diagnosis and prognosis models for hepatocellular carcinoma patient’s management based on tumor mutation burden. Journal of Advanced Research 2021; 33: 153 doi: 10.1016/j.jare.2021.01.018
34
Mariam Mroweh, Gaël Roth, Thomas Decaens, Patrice N. Marche, Hervé Lerat, Zuzana Macek Jílková. Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment. International Journal of Molecular Sciences 2021; 22(4): 1794 doi: 10.3390/ijms22041794
35
Pelin BALÇIK ERÇİN. Integrative Analysis of SIX1 and Cancer Stem Cell Markers in Hepatocellular Carcinoma. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 2020; 7(3): 325 doi: 10.34087/cbusbed.689797
36
Koen C. van Son, Lars Verschuren, Roeland Hanemaaijer, Helen Reeves, R. Bart Takkenberg, Joost P. H. Drenth, Maarten E. Tushuizen, Adriaan G. Holleboom. Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease. Cancers 2023; 15(4): 1308 doi: 10.3390/cancers15041308
37
Rong Ke, Navin Viswakarma, Mary Menhart, Sunil Kumar Singh, Sandeep Kumar, Piush Srivastava, Kanchan Vishnoi, Tanushree Kashyap, Deepti Srivastava, Rakesh Sathish Nair, Mark Maienschein-Cline, Xiaowei Wang, Ajay Rana, Basabi Rana. MLK3 promotes prooncogenic signaling in hepatocellular carcinoma via TGFβ pathway. Oncogene 2024; 43(30): 2307 doi: 10.1038/s41388-024-03055-8
38
Sindhia Kumari, Arslan Ali, Talat Roome, Anam Razzak, Ayesha Iqbal, Amna Jabbar Siddiqui, Syed Muhammad Zahid Azam, Hafeezullah Shaikh, Hesham R. El-Seedi, Syed Ghulam Musharraf. Metabolomics approach to understand the hepatitis C virus induced hepatocellular carcinoma using LC-ESI-MS/MS. Arabian Journal of Chemistry 2021; 14(1): 102907 doi: 10.1016/j.arabjc.2020.11.013
39
Mario Romeo, Marcello Dallio, Flavia Scognamiglio, Lorenzo Ventriglia, Marina Cipullo, Annachiara Coppola, Chiara Tammaro, Giuseppe Scafuro, Patrizia Iodice, Alessandro Federico. Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. Cancers 2023; 15(21): 5178 doi: 10.3390/cancers15215178
40
Jianwei Wang, Xiaowen Guan, Ning Shang, Di Wu, Zihan Liu, Zhenzhen Guan, Zhizi Zhang, Zhongzhen Jin, Xiaoyi Wei, Xiaoran Liu, Mingzhu Song, Weijun Zhu, Guifu Dai. Dysfunction of CCT3-associated network signals for the critical state during progression of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(4): 167054 doi: 10.1016/j.bbadis.2024.167054
41
Jiamei Luo, Teng Wang, Xiaoqiang Wang, Yumiao Shi, Yiqi Zhang, Jie Tian, Yin Gong. Ficolin-3 may act as a tumour suppressor by recognising O-GlcNAcylation site in hepatocellular carcinoma. Medical Hypotheses 2022; 166: 110899 doi: 10.1016/j.mehy.2022.110899
42
Mengmeng Wang, Xiongjun Yang, Yajun Meng, Ze Jin, Jiali Cao, Lina Xiong, Zhifan Xiong. Comprehensive analysis of the tumor-promoting effect and immune infiltration correlation MAZ from pan-cancer to hepatocellular carcinoma. International Immunopharmacology 2023; 115: 109660 doi: 10.1016/j.intimp.2022.109660
43
Ibrahim Abdel Aziz Ibrahim, Abdullah R Alzahrani, Ibrahim Alanazi, Naiyer Shahzad, Imran Shahid, Alaa Falemban, Mohd Fahami Nur Azlina, Palanisamy Arulselvan. Synthesis and Characterization of Graphene Oxide/Polyethylene Glycol/Folic Acid/Brucine Nanocomposites and Their Anticancer Activity on HepG2 Cells. International Journal of Nanomedicine 2024; : 1109 doi: 10.2147/IJN.S445206
44
Yilin Tian, Jing Lu, Yongxia Qiao. A metabolism-associated gene signature for prognosis prediction of hepatocellular carcinoma. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.988323
45
Tahereh Tajik, Kaveh Baghaei, Vahid Erfani Moghadam, Naser Farrokhi, Seyed Alireza Salami. Extracellular vesicles of cannabis with high CBD content induce anticancer signaling in human hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2022; 152: 113209 doi: 10.1016/j.biopha.2022.113209
46
Hu Li, Pengbo Hu, Yajun Zou, Lijuan Yuan, Yucheng Xu, Xiaohui Zhang, Xiaoyan Luo, Zhiqiang Zhang. Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1071415
47
Xinxin Chen, Jin Li, Yuhong Huang, Chao Liang. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 3: 325 doi: 10.1007/16833_2022_110
48
Stuti Bhagat, Sanjay Singh. Use of antioxidant nanoliposomes for co-delivery of PTEN plasmids and plumbagin to induce apoptosis in hepatic cancer cells. Biomedical Materials 2024; 19(2): 025026 doi: 10.1088/1748-605X/ad1dff
49
Yating Xu, Xiao Yu, Zongzong Sun, Yuting He, Wenzhi Guo. Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCC. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.831366
50
Song Gao, Xingyue Jiang, Liang Wang, Shanshan Jiang, Hanyuan Luo, Yan Chen, Cheng Peng. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1029601
51
Jianhua Wu, Xueting Ren, Nan Wang, Ruina Zhou, Mengsha Chen, Yifan Cai, Shuai Lin, Hao Zhang, Xin Xie, Chengxue Dang, Shuqun Zhang, Zhangjian Zhou. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.779554
52
Jingyu Xiao, Fei Wang, Xiaoyan Hu, Dongli Li, Geng Liu, Qumiao Xu, Chao Chen, Haitao Xiang, Xuan Dong, Linnan Zhu, Dishuang Yang, Yanan Gao, Meijuan Wang, Yonglun Luo, Cheng‐Chi Chao, Guanglei Li, Qiongyu Guo. Engineering In Vitro Organ‐Structured Tumor Model for Evaluating Neoantigen‐Specific T Cell Responses in Hepatocellular Carcinoma. Advanced Materials Interfaces 2023; 10(24) doi: 10.1002/admi.202300155
53
Ilkyu Park, Hyo-Bin Lee, Nakyoung Kim, Sugi Lee, Kunhyang Park, Mi-Young Son, Hyun-Soo Cho, Dae-Soo Kim. Uncovering gene expression signatures and diagnostic – Biomarkers in hepatocellular carcinoma through multinomial logistic regression analysis. Journal of Biotechnology 2024; 395: 31 doi: 10.1016/j.jbiotec.2024.09.003
54
Bilal Rah, Nada Mazen Farhat, Mawieh Hamad, Jibran Sualeh Muhammad. JAK/STAT signaling and cellular iron metabolism in hepatocellular carcinoma: therapeutic implications. Clinical and Experimental Medicine 2023; 23(7): 3147 doi: 10.1007/s10238-023-01047-8
55
Francisco D. Rodriguez, Rafael Coveñas. Biochemical Mechanisms Associating Alcohol Use Disorders with Cancers. Cancers 2021; 13(14): 3548 doi: 10.3390/cancers13143548
56
Gaoxiang Li, Yazhi Qian, Yuzhu Chen, Mingyue Cao, Xiaozhou Yang, Dexin Kong, Guiping Wang, Haiyan An, Nan Yang, Wei Huang, Yanyong Liu. Wip1 contributes to the adaptation of HepG2 human liver cancer cells to stress hormone‑induced DNA damage. Oncology Letters 2022; 25(1) doi: 10.3892/ol.2022.13617
57
Iman M. El-Zehery, Mohamed El-Mesery, Mohamed El-Sherbiny, Amal M. El Gayar, Nada H. Eisa. Carbenoxolone upregulates TRAIL\TRAILR2 expression and enhances the anti-neoplastic effect of doxorubicin in experimentally induced hepatocellular carcinoma in rats. Biochemical and Biophysical Research Communications 2024; : 150876 doi: 10.1016/j.bbrc.2024.150876
58
Nehal M. Elsherbiny, Nada H. Eisa, Mohamed El-Sherbiny, Eman Said. Chemo-preventive effect of crocin against experimentally-induced hepatocarcinogenesis via regulation of apoptotic and Nrf2 signaling pathways. Environmental Toxicology and Pharmacology 2020; 80: 103494 doi: 10.1016/j.etap.2020.103494
59
Ye Xu, Qinglong Guo, Libin Wei. The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma. Cancers 2021; 13(20): 5096 doi: 10.3390/cancers13205096
60
Dafeng Xu, Yu Wang, Jincai Wu, Shixun Lin, Yonghai Chen, Jinfang Zheng. Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02326-8
61
Peng Zhu, Yongyan Pei, Jian Yu, Wenbin Ding, Yun Yang, Fuchen Liu, Lei Liu, Jian Huang, Shengxian Yuan, Zongyan Wang, Fangming Gu, Zeya Pan, Jinzhong Chen, Jinrong Qiu, Huiying Liu. High-throughput sequencing approach for the identification of lncRNA biomarkers in hepatocellular carcinoma and revealing the effect of ZFAS1/miR-150-5p on hepatocellular carcinoma progression. PeerJ 2023; 11: e14891 doi: 10.7717/peerj.14891
62
Qing-Shuai Ren, Qiu Sun, Shu-Qin Cheng, Li-Ming Du, Ping-Xuan Guo. Hepatocellular carcinoma: An analysis of the expression status of stress granules and their prognostic value. World Journal of Gastrointestinal Oncology 2024; 16(6): 2571-2591 doi: 10.4251/wjgo.v16.i6.2571
63
Caiqun Bie, Yanfang Chen, Huijun Tang, Qing Li, Lu Zhong, Xiaojuan Peng, Ying Shi, Junqin Lin, Junlong Lai, Shenglan Wu, Shaohui Tang. Insulin-Like Growth Factor 1 Receptor Drives Hepatocellular Carcinoma Growth and Invasion by Activating Stat3-Midkine-Stat3 Loop. Digestive Diseases and Sciences 2022; 67(2): 569 doi: 10.1007/s10620-021-06862-1
64
Tao Wan, Xueqin Gan, Weijie Xiong. Efficacy and safety of hepatic arterial infusion chemotherapy combined with donafenib in the treatment of unresectable hepatocellular carcinoma. Asia-Pacific Journal of Clinical Oncology 2024; 20(6): 747 doi: 10.1111/ajco.14105
65
Kalyani Patil, Said Dermime, Shahab Uddin. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 301 doi: 10.1016/B978-0-323-99283-1.00016-1
66
Hara Afaloniati, Katerina Angelopoulou, Alexander Giakoustidis, Alexandros Hardas, Athanasios Pseftogas, Kali Makedou, Athanasios Gargavanis, Thomas Goulopoulos, Stavros Iliadis, Vasileios Papadopoulos, Apostolos Papalois, George Mosialos, Theofilos Poutahidis, Dimitrios Giakoustidis. <p>HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice</p>. OncoTargets and Therapy 2020; : 5575 doi: 10.2147/OTT.S250233
67
Nan Jiang, Binyan Zhong, Jintao Huang, Wanci Li, Shuai Zhang, Xiaoli Zhu, Caifang Ni, Jian Shen. Transarterial chemoembolization combined with molecularly targeted agents plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma: a retrospective cohort study. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1205636
68
Hong Zhao, Yujie Wang, Yufeng Liu, Xiaohua Hao, Hongshan Wei, Wen Xie. The Effect of Protein FAM172A on Proliferation in HepG2 Cells and Investigation of the Possible Molecular Mechanism. Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/5901083
69
Pinar Erkekoglu, Suna Sabuncuoğlu. Liver Cancer in the Middle East. 2021; : 31 doi: 10.1007/978-3-030-78737-0_3
70
Michele Dal Bo, Elena De Mattia, Lorena Baboci, Silvia Mezzalira, Erika Cecchin, Yehuda G. Assaraf, Giuseppe Toffoli. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma. Drug Resistance Updates 2020; 51: 100702 doi: 10.1016/j.drup.2020.100702
71
Xingyun Wu, Zihao Wang, Li Luo, Dan Shu, Kui Wang. Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine. Frontiers in Medical Technology 2023; 4 doi: 10.3389/fmedt.2022.1065506
72
Sanjit Boora, Vikrant Sharma, Sulochana Kaushik, Ajoy Varma Bhupatiraju, Sandeep Singh, Samander Kaushik. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem. Brazilian Journal of Microbiology 2023; 54(2): 679 doi: 10.1007/s42770-023-00970-y
73
Payal Deepak, Praveen Kumar, Dilip Kumar Arya, Prashant Pandey, Shiv Kumar, Bishnu Prasad Parida, Gopeshwar Narayan, Sanjay Singh, Paruvathanahalli Siddalingam Rajinikanth. c(RGDfK) anchored surface manipulated liposome for tumor-targeted tyrosine kinase inhibitor (TKI) delivery to potentiate liver anticancer activity. International Journal of Pharmaceutics 2023; 642: 123160 doi: 10.1016/j.ijpharm.2023.123160
74
Huangru Xu, Ping Li, Xiaoyang Wang, Hongqin Zhuang, Zi-Chun Hua. Emerging roles of hnRNP A2B1 in cancer and inflammation. International Journal of Biological Macromolecules 2022; 221: 1077 doi: 10.1016/j.ijbiomac.2022.09.104
75
Mariam Mroweh, Thomas Decaens, Patrice N Marche, Zuzana Macek Jilkova, Flora Clément. Modulating the Crosstalk between the Tumor and Its Microenvironment Using RNA Interference: A Treatment Strategy for Hepatocellular Carcinoma. International Journal of Molecular Sciences 2020; 21(15): 5250 doi: 10.3390/ijms21155250
76
Ning Dimin, Deng Zhe, Wu Yongrong, Mei Si, Teng Yongjie, Zhou Qing, Tian Xuefei. Niuhuang (Bovis Calculus)-Shexiang (Moschus) combination induces apoptosis and inhibits proliferation in hepatocellular carcinoma via PI3K/AKT/mTOR pathway. Digital Chinese Medicine 2022; 5(1): 83 doi: 10.1016/j.dcmed.2022.03.009
77
Jinzhao Yang, Jie Chen, Qingqing Li, Ren-ai Xu, Xiaohai Chen. Effects of three flavonoids on the metabolism of lenvatinib. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1438259
78
Yonggui Zhang, Xuefeng Jiang, Xiangjun Li, Mihnea-Alexandru Găman, Hamed Kord-Varkaneh, Jamal Rahmani, Ammar Salehi-Sahlabadi, Andrew S Day, Yan Xu. Serum Vitamin D Levels and Risk of Liver Cancer: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies. Nutrition and Cancer 2021; 73(8): 1 doi: 10.1080/01635581.2020.1797127
79
Ahmad Khan, Xiaobo Zhang. Function of the Long Noncoding RNAs in Hepatocellular Carcinoma: Classification, Molecular Mechanisms, and Significant Therapeutic Potentials. Bioengineering 2022; 9(8): 406 doi: 10.3390/bioengineering9080406
80
Ji Hoon Jung, Hyo-Jung Lee, Ju-Ha Kim, Deok Yong Sim, Eunji Im, Sinae Kim, Suhwan Chang, Sung-Hoon Kim. Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2. Cells 2020; 9(4): 985 doi: 10.3390/cells9040985
81
Zhenzhen Su, Limei Luo, Xiaojuan Wu, Bin Wei, Lu Wang, Fei Liu, Bei Cai. Association of the MARCO polymorphism rs6761637 with hepatocellular carcinoma susceptibility and clinical characteristics. Immunologic Research 2022; 70(3): 400 doi: 10.1007/s12026-022-09271-2
82
Zhicheng Yao, Ruiyun Xu, Lin Yuan, Mingxing Xu, Haiyun Zhuang, Yanjie Li, Yi Zhang, Nan Lin. Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11. Cell Death & Disease 2019; 10(12) doi: 10.1038/s41419-019-2176-y
83
Bao-Kang Wu, Qian-Hui Chen, Dan Pan, Bing Chang, Li-Xuan Sang. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulatory mechanisms of selenium and/or selenoproteins on a shift towards anti-cancer. International Immunopharmacology 2021; 96: 107790 doi: 10.1016/j.intimp.2021.107790
84
Hui Zheng, Xu Han, Qian Liu, Li Zhou, Yawen Zhu, Jiaqi Wang, Wenjing Hu, Fengcai Zhu, Ran Liu. Construction of immune-related molecular diagnostic and predictive models of hepatocellular carcinoma based on machine learning. Heliyon 2024; 10(2): e24854 doi: 10.1016/j.heliyon.2024.e24854
85
Anna Buttell, Wei Qiu. The action and resistance mechanisms of Lenvatinib in liver cancer. Molecular Carcinogenesis 2023; 62(12): 1918 doi: 10.1002/mc.23625
86
Yu Jin Kim, Nayeong Yuk, Hee Jeong Shin, Hye Jin Jung. The Natural Pigment Violacein Potentially Suppresses the Proliferation and Stemness of Hepatocellular Carcinoma Cells In Vitro. International Journal of Molecular Sciences 2021; 22(19): 10731 doi: 10.3390/ijms221910731
87
Lin Xing, Yuting Tang, Lu Li, Xufeng Tao. ROS in hepatocellular carcinoma: What we know. Archives of Biochemistry and Biophysics 2023; 744: 109699 doi: 10.1016/j.abb.2023.109699
88
Ilaria Chiodi, Chiara Mondello. Life style factors, tumor cell plasticity and cancer stem cells. Mutation Research/Reviews in Mutation Research 2020; 784: 108308 doi: 10.1016/j.mrrev.2020.108308
89
Qicong Mai, Dafeng Sheng, Chengcong Chen, Qing Gou, Meng Chen, Xiaoting Huang, Heng Yin, Xiaoming Chen, Zide Chen. Steroid 5 alpha-reductase 3 (SRD5A3) promotes tumor growth and predicts poor survival of human hepatocellular carcinoma (HCC). Aging 2020; 12(24): 25395 doi: 10.18632/aging.104142
90
Yi-Ning Du, Jin-Wei Zhao. GDF15: Immunomodulatory Role in Hepatocellular Carcinoma Pathogenesis and Therapeutic Implications. Journal of Hepatocellular Carcinoma 2024; : 1171 doi: 10.2147/JHC.S471239
91
Julie Pellegrinelli, Olivier Chevallier, Sylvain Manfredi, Inna Dygai-Cochet, Claire Tabouret-Viaud, Guillaume Nodari, François Ghiringhelli, Jean-Marc Riedinger, Romain Popoff, Jean-Marc Vrigneaud, Alexandre Cochet, Serge Aho, Marianne Latournerie, Romaric Loffroy. Transarterial Radioembolization of Hepatocellular Carcinoma, Liver-Dominant Hepatic Colorectal Cancer Metastases, and Cholangiocarcinoma Using Yttrium90 Microspheres: Eight-Year Single-Center Real-Life Experience. Diagnostics 2021; 11(1): 122 doi: 10.3390/diagnostics11010122
92
Jacek Baj, Magdalena Kołodziej, Joanna Kobak, Jacek Januszewski, Kinga Syty, Piero Portincasa, Alicja Forma. Significance of Immune and Non-Immune Cell Stroma as a Microenvironment of Hepatocellular Carcinoma—From Inflammation to Hepatocellular Carcinoma Progression. International Journal of Molecular Sciences 2024; 25(19): 10233 doi: 10.3390/ijms251910233
93
Xiufen Zhang, Sui Xu, Caixia Hu, Kai Fang, Junjing Zhou, Zijian Guo, Guoding Zhu, Lihua Li. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma progression by regulating MAGEA3 and DCAF4L2 expression. Biochemical and Biophysical Research Communications 2020; 533(4): 1039 doi: 10.1016/j.bbrc.2020.09.115
94
Jie Chen, Xicheng Wang, Xining Wang, Wenxin Li, Changzhen Shang, Tao Chen, Yajin Chen. A FITM1-Related Methylation Signature Predicts the Prognosis of Patients With Non-Viral Hepatocellular Carcinoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00099
95
Anna Rossetto, Valli De Re, Agostino Steffan, Matteo Ravaioli, Gianmaria Miolo, Patrizia Leone, Vito Racanelli, Alessandro Uzzau, Umberto Baccarani, Matteo Cescon. Carcinogenesis and Metastasis in Liver: Cell Physiological Basis. Cancers 2019; 11(11): 1731 doi: 10.3390/cancers11111731
96
Giulia Orsi, Francesco Tovoli, Vincenzo Dadduzio, Caterina Vivaldi, Oronzo Brunetti, Luca Ielasi, Fabio Conti, Giulia Rovesti, Laura Gramantieri, Mario Domenico Rizzato, Irene Pecora, Antonella Argentiero, Federica Teglia, Sara Lonardi, Francesca Salani, Alessandro Granito, Vittorina Zagonel, Giorgia Marisi, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Francesca Benevento, Alessandro Cucchetti, Fabio Piscaglia, Stefano Cascinu, Mario Scartozzi, Andrea Casadei-Gardini. Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma. Targeted Oncology 2020; 15(6): 773 doi: 10.1007/s11523-020-00757-3
97
Francesca V. LoBianco, Kimberly J. Krager, Erica Johnson, Christopher O. Godwin, Antino R. Allen, Peter A. Crooks, Cesar M. Compadre, Michael J. Borrelli, Nukhet Aykin-Burns. Parthenolide induces rapid thiol oxidation that leads to ferroptosis in hepatocellular carcinoma cells. Frontiers in Toxicology 2022; 4 doi: 10.3389/ftox.2022.936149
98
Yipeng Zhang, Lijun Li, Renzhi Liu, Changchun Zeng. DNA Primase Subunit 1 Expression in Hepatocellular Carcinoma and Its Clinical Implication. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9689312
99
Tianhang Feng, Ping Chen, Tao Wang, Chunyou Lai, Yutong Yao. Integrated clinical and prognostic analyses of mTOR/Hippo pathway core genes in hepatocellular carcinoma. Journal of Physiology and Biochemistry 2024; 80(2): 439 doi: 10.1007/s13105-024-01015-0
100
Muhammed Mehdi Üremiş, Nuray Üremiş, Emir Tosun, Merve Durhan, Yılmaz Çiğremiş, Ahmet Baysar, Yusuf Türköz. Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling Pathways. Current Cancer Drug Targets 2022; 22(11): 931 doi: 10.2174/1568009622666220623141158
101
Wu Xing, Peng‐Cheng Zhou, Hao‐Ye Zhang, Li‐Min Chen, Yang‐Mei Zhou, Xue‐Fei Cui, Zhen‐Guo Liu. Circular RNA circ_GLIS2 suppresses hepatocellular carcinoma growth and metastasis. Liver International 2022; 42(3): 682 doi: 10.1111/liv.15097
102
Sanya Batheja, Rakesh Kumar Sahoo, Sofiya Tarannum, Klaudi K. Vaiphei, Shikha Jha, Amit Alexander, Amit Kumar Goyal, Umesh Gupta. Hepatocellular carcinoma: Preclinical and clinical applications of nanotechnology with the potential role of carbohydrate receptors. Biochimica et Biophysica Acta (BBA) - General Subjects 2023; 1867(10): 130443 doi: 10.1016/j.bbagen.2023.130443
103
Tao Wu, Li Liao, Tao Wu, Shuai Chen, Qilin Yi, Min Xu. IGF2BP2 promotes glycolysis and hepatocellular carcinoma stemness by stabilizing CDC45 mRNA via m6A modification. Cell Cycle 2023; 22(20): 2245 doi: 10.1080/15384101.2023.2283328
104
Dazhi Tian, Yang Yu, Li Zhang, Jisan Sun, Wentao Jiang. 23-hydroxybetulinic acid reduces tumorigenesis, metastasis and immunosuppression in a mouse model of hepatocellular carcinoma via disruption of the MAPK signaling pathway. Anti-Cancer Drugs 2022; 33(9): 815 doi: 10.1097/CAD.0000000000001325
105
Linmeng Han, Chunyu Zhang, Danni Wang, Jiaqi Zhang, Qiqi Tang, Mulin Jun Li, Michael N. Sack, Lingdi Wang, Lu Zhu. Retrograde regulation of mitochondrial fission and epithelial to mesenchymal transition in hepatocellular carcinoma by GCN5L1. Oncogene 2023;  doi: 10.1038/s41388-023-02621-w
106
Runjie Song, Shuoqian Ma, Jiajia Xu, Xin Ren, Peilan Guo, Huijiao Liu, Peng Li, Fan Yin, Mei Liu, Qiang Wang, Lei Yu, Jiali Liu, Binwei Duan, Nafis A. Rahman, Sławomir Wołczyński, Guangming Li, Xiangdong Li. A novel polypeptide encoded by the circular RNA ZKSCAN1 suppresses HCC via degradation of mTOR. Molecular Cancer 2023; 22(1) doi: 10.1186/s12943-023-01719-9
107
Hassan Akrami, Hanieh Gholami, Mohammad Reza Fattahi, Mastaneh Zeraatiannejad. Effect of miR-4270 Suppression on Migration in Hepatocellular Carcinoma Cell Line (HepG2). Iranian Biomedical Journal 2023; 27(4): 167 doi: 10.61186/ibj.3923
108
Cho-Won Kim, Hong Kyu Lee, Min-Woo Nam, Youngdong Choi, Kyung-Chul Choi. Overexpression of KiSS1 Induces the Proliferation of Hepatocarcinoma and Increases Metastatic Potential by Increasing Migratory Ability and Angiogenic Capacity. Molecules and Cells 2022; 45(12): 935 doi: 10.14348/molcells.2022.0105
109
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, Craig McFarlane, Lionel Hebbard. Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data. Seminars in Cancer Biology 2022; 86: 799 doi: 10.1016/j.semcancer.2022.01.005
110
Wei Guan, Wang Qi. Ginsenoside Rh2: A shining and potential natural product in the treatment of human nonmalignant and malignant diseases in the near future. Phytomedicine 2023; 118: 154938 doi: 10.1016/j.phymed.2023.154938
111
Ehab Kotb Elmahallawy, Yasser Mohamed, Walied Abdo, Tokuma Yanai. Melatonin and Mesenchymal Stem Cells as a Key for Functional Integrity for Liver Cancer Treatment. International Journal of Molecular Sciences 2020; 21(12): 4521 doi: 10.3390/ijms21124521
112
Jasem Albarrak, Humaid Al-Shamsi. Current Status of Management of Hepatocellular Carcinoma in The Gulf Region: Challenges and Recommendations. Cancers 2023; 15(7): 2001 doi: 10.3390/cancers15072001
113
Shahnaz Azzahra, Ulfa Kholili, Rosy Setiawati, Ummi Maimunah. Profile of Patients of Hepatocellular Carcinoma in The Internal Medicine Inpatient Room at Dr. Soetomo General Academic Hospital . Current Internal Medicine Research and Practice Surabaya Journal 2023; 4(1): 1 doi: 10.20473/cimrj.v4i1.42287
114
Aqsa Nazir, Muhammad Aqib, Muhammad Usman. Liver Cancer - Genesis, Progression and Metastasis. 2023;  doi: 10.5772/intechopen.106020
115
Amna Mohamed Taha, Mohammad Mabrouk Aboulwafa, Hamdallah Zedan, Omneya Mohamed Helmy. Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21582-w
116
Frédéric Geinguenaud, Odile Sainte‐Catherine, Florence Poirier, Valérie Besnard, Oualid Haddad, Frédéric Chaubet, Yoann Lalatonne, Didier Lutomski, Angela Sutton, Laurence Motte. Iron Oxide Nanoparticles Functionalized with Fucoidan: a Potential Theranostic Nanotool for Hepatocellular Carcinoma. ChemBioChem 2022; 23(16) doi: 10.1002/cbic.202200265
117
Aalok Basu, Thanaphon Namporn, Pakatip Ruenraroengsak. Critical Review in Designing Plant-Based Anticancer Nanoparticles against Hepatocellular Carcinoma. Pharmaceutics 2023; 15(6): 1611 doi: 10.3390/pharmaceutics15061611
118
Qirui Lin. Inactivation of ERK1/2 in cancer-associated hepatic stellate cells suppresses cancer-stromal interaction by regulating extracellular matrix in fibrosis. American Journal of Cancer Research 2024; 14(3): 1015 doi: 10.62347/VPYE3817
119
Jade Cochard, Anne Bull‐Maurer, Clovis Tauber, Julien Burlaud‐Gaillard, Frédéric Mazurier, Jean‐Christophe Meunier, Philippe Roingeard, Philippe Chouteau. Differentiated Cells in Prolonged Hypoxia Produce Highly Infectious Native‐Like Hepatitis C Virus Particles. Hepatology 2021; 74(2): 627 doi: 10.1002/hep.31788
120
Ann Abd-Almonem Farid, Nermin Abd-Almaksoud Afify, Aml Abd-Alhamid Alsharnoby, Eman Abdelsameea, Hanan M. Bedair. Predictive Role of AURKA rs 1047972 Gene Polymorphism and the Risk of Development of Hepatocellular Carcinoma. Immunological Investigations 2022; 51(5): 1211 doi: 10.1080/08820139.2021.1920609
121
Meenakshi Gupta, Shaikh Maryam Ghufran, Tasneem Kausar, Rafat Ali, Subhrajit Biswas, Shahid M. Nayeem, Romana Ishrat, Sher Ali, Ajaz Ahmad, Irfan A. Rather, Maryam Sarwat. Z-Guggulsterone Is a Potential Lead Molecule of Dawa-ul-Kurkum against Hepatocellular Carcinoma. Molecules 2022; 27(16): 5104 doi: 10.3390/molecules27165104
122
C. Wen, R. L. Shi, Y. L. An, S. T. Zhang, T. Wang, H. Luo. A Comprehensive Functional Analysis Indicates CNDP1 Mitigates Hepatocellular Carcinoma and May Be Associated with Immune Cell Infiltration and m6A-Related Genes. Russian Journal of Genetics 2024; 60(9): 1264 doi: 10.1134/S1022795424700807
123
Kiyoon Min, Sathish Kumar Karuppannan, Giyoong Tae. The impact of matrix stiffness on hepatic cell function, liver fibrosis, and hepatocellular carcinoma—Based on quantitative data. Biophysics Reviews 2024; 5(2) doi: 10.1063/5.0197875
124
Naima Zayed Mohamed, Hanan Farouk Aly, Hatem Abdel moneim El-Mezayen, Hadeer E. El-Salamony. Effect of co-administration of Bee honey and some chemotherapeutic drugs on dissemination of hepatocellular carcinoma in rats. Toxicology Reports 2019; 6: 875 doi: 10.1016/j.toxrep.2019.08.007
125
Limei Zhang, Jinfu Wang, Weiping Deng, Fenfang Gui, Fanzhou Peng, Qian Zhu. Solamargine Induces Hepatocellular Carcinoma Cell Apoptosis and Ferroptosis via Regulating STAT1/MTCH1 Axis. Biochemical Genetics 2024;  doi: 10.1007/s10528-024-10749-x
126
Ping Chen, Xiaomeng Liu, Yayue Liu, Xu Bao, Qiang Wu. ARHGAP18 is Upregulated by Transcription Factor GATA1 Promotes the Proliferation and Invasion in Hepatocellular Carcinoma. Applied Biochemistry and Biotechnology 2024; 196(2): 679 doi: 10.1007/s12010-023-04459-0
127
Zehra Omeroglu Ulu, Zeynep Busra Bolat, Fikrettin Sahin. Integrated transcriptome and in vitro analysis revealed anti-proliferative effect of sodium perborate on hepatocellular carcinoma cells. Journal of Trace Elements in Medicine and Biology 2022; 73: 127011 doi: 10.1016/j.jtemb.2022.127011
128
Jie Kong, Tingfeng Huang, Jianxi Zhang, Shichuan Tang, Hongzhi Liu, Jingfeng Liu, Yongyi Zeng. Analysis of conditional survival in primary hepatocellular carcinoma after narrow-margin hepatectomy: a large-sample, dual-centre, retrospective study. HPB 2023; 25(2): 179 doi: 10.1016/j.hpb.2022.08.005
129
Anna Santarsiero, Ilaria Pappalardo, Gabriella Margherita Rosa, Isabella Pisano, Stefano Superchi, Paolo Convertini, Simona Todisco, Patrizia Scafato, Vittoria Infantino. Mitochondrial Role in Intrinsic Apoptosis Induced by a New Synthesized Chalcone in Hepatocellular Carcinoma Cells. Biomedicines 2022; 10(12): 3120 doi: 10.3390/biomedicines10123120
130
Davide Ippolito, Cesare Maino, Marco Gatti, Paolo Marra, Riccardo Faletti, Francesco Cortese, Riccardo Inchingolo, Sandro Sironi. Radiological findings in non-surgical recurrent hepatocellular carcinoma: From locoregional treatments to immunotherapy. World Journal of Gastroenterology 2023; 29(11): 1669-1684 doi: 10.3748/wjg.v29.i11.1669
131
Hai-Chen Wang, Wen-Xuan Yin, Meng Jiang, Jia-Yi Han, Xing-Wang Kuai, Rui Sun, Yu-Feng Sun, Ju-Ling Ji. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(39): 5435-5451 doi: 10.3748/wjg.v29.i39.5435
132
Wenyuan Zhang, Chongling Zhang, Shixin Liu, Yongjing Yang. Study on biological activity and p38 mitogen-activated protein kinases of magnetic nanoparticles on hepatoma cells. Materials Express 2023; 13(6): 961 doi: 10.1166/mex.2023.2428
133
Lei Chen, Dafang Zhang, Shengmin Zheng, Xinyu Li, Pengji Gao. Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene–related signature associated with prognosis and therapy response. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.959834
134
Maryam Ranjpour, Saima Wajid, Swatantra Kumar Jain. Elevated expression of sepiapterin reductase, regulator of G protein signaling 1, hypothetical protein CXorf58 homolog, and zinc finger and BTB domain–containing protein 21 isoform X2 is associated with progression of hepatocellular carcinoma. Protoplasma 2021; 258(5): 1133 doi: 10.1007/s00709-021-01632-2
135
Yan Su, Ruizhu Xie, Qinyan Xu. LncRNA THAP9-AS1 highly expressed in tissues of hepatocellular carcinoma and accelerates tumor cell proliferation. Clinics and Research in Hepatology and Gastroenterology 2022; 46(10): 102025 doi: 10.1016/j.clinre.2022.102025
136
Yun Zhang, Li Shen, Bojun Wang, Xiaohong Wu. Ethanolamine-phosphate phospho-lyase (ETNPPL) contributes to the diagnosis, prognosis, and therapy of hepatocellular carcinoma. PeerJ 2023; 11: e15834 doi: 10.7717/peerj.15834
137
Hae Il Jung, Hyein Ahn, Mee-Hye Oh, JongHyuk Yun, Hyunyong Lee, Sang Ho Bae, Yung Kil Kim, Sung Yong Kim, Moo-Jun Baek, Moon-Soo Lee. Prognostic significance of programmed cell death-ligand 1 expression on immune cells and epithelial-mesenchymal transition expression in patients with hepatocellular carcinoma. Annals of Surgical Treatment and Research 2023; 105(5): 297 doi: 10.4174/astr.2023.105.5.297
138
Leticia Bucio-Ortiz, Karina Enriquez-Navarro, Angélica Maldonado-Rodríguez, Jesús Torres-Flores, Ana Cevallos, Mauricio Salcedo, Rosalia Lira. Occult Hepatitis B Virus Infection in Hepatic Diseases and Its Significance for the WHO’s Elimination Plan of Viral Hepatitis. Pathogens 2024; 13(8): 662 doi: 10.3390/pathogens13080662
139
Yilihamu Maimaiti, Aihesan Kamali, Peng Yang, Kai Zhong, Xiaokaiti Abuduhadeer. Hsa_circ_0008092 Contributes to Cell Proliferation and Metastasis in Hepatocellular Carcinoma via the miR-502-5p/CCND1 Axis. Protein & Peptide Letters 2022; 29(7): 595 doi: 10.2174/0929866529666220721090209
140
Tejveer Singh, Deepika Sharma, Rishabh Sharma, Hardeep Singh Tuli, Shafiul Haque, Seema Ramniwas, Darin Mansor Mathkor, Vikas Yadav. The Role of Phytonutrient Kaempferol in the Prevention of Gastrointestinal Cancers: Recent Trends and Future Perspectives. Cancers 2024; 16(9): 1711 doi: 10.3390/cancers16091711
141
Jeannette Huaman, Olorunseun O. Ogunwobi. Circulating Tumor Cell Migration Requires Fibronectin Acting through Integrin B1 or SLUG. Cells 2020; 9(7): 1594 doi: 10.3390/cells9071594
142
Ángel M. Cuesta, Nerea Palao, Paloma Bragado, Alvaro Gutierrez-Uzquiza, Blanca Herrera, Aránzazu Sánchez, Almudena Porras. New and Old Key Players in Liver Cancer. International Journal of Molecular Sciences 2023; 24(24): 17152 doi: 10.3390/ijms242417152
143
Chengwu Zeng, Wanxu Huang, Yangqiu Li, Hengyou Weng. Roles of METTL3 in cancer: mechanisms and therapeutic targeting. Journal of Hematology & Oncology 2020; 13(1) doi: 10.1186/s13045-020-00951-w
144
Ziqi Meng, Jiarui Wu, Xinkui Liu, Wei Zhou, Mengwei Ni, Shuyu Liu, Siyu Guo, Shanshan Jia, Jingyuan Zhang. Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis. Journal of International Medical Research 2020; 48(7) doi: 10.1177/0300060520910019
145
Zhiwei Shao, Haoqi Pan, Sheng Tu, Jingying Zhang, Sheng Yan, Anwen Shao. HGF/c-Met Axis: The Advanced Development in Digestive System Cancer. Frontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00801
146
Tennyson Prakash Rayginia, Chenicheri Kizhakkeveettil Keerthana, Sadiq Chembothumparambil Shifana, Maria Joy Pellissery, Ajmani Abhishek, Ruby John Anto. Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma. Current Medicinal Chemistry 2024; 31(32): 5199 doi: 10.2174/0109298673275501231213063902
147
Yu Gan, Weidan Fang, Yan Zeng, Peijun Wang, Renfeng Shan, Ling Zhang. Identification of a Novel Survival-Related circRNA–miRNA–mRNA Regulatory Network Related to Immune Infiltration in Liver Hepatocellular Carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.800537
148
Jeannette Huaman, Michelle Naidoo, Xingxing Zang, Olorunseun O. Ogunwobi. Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells. Cells 2019; 8(6): 618 doi: 10.3390/cells8060618
149
Anna Kakehashi, Shugo Suzuki, Hideki Wanibuchi. Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis. Cancers 2023; 15(18): 4566 doi: 10.3390/cancers15184566
150
Haibo Ding, Donghua Dai, Ammena Y. Binsaleh, Attalla F. El-kott, Fatimah A. Al-Saeed. Green Immobilized Silver Nanoparticles Over Mentha spicata Flower Extract Modified Reduced Graphene Oxide: Investigation of its Antioxidant and Anti-liver Cancer Effects. Journal of Inorganic and Organometallic Polymers and Materials 2024; 34(3): 1369 doi: 10.1007/s10904-023-02843-1
151
Kenya Kamimura, Takeshi Yokoo, Hiroyuki Abe, Shuji Terai. Gene Therapy for Liver Cancers: Current Status from Basic to Clinics. Cancers 2019; 11(12): 1865 doi: 10.3390/cancers11121865
152
Huijie Zhao, Yiming Zhang, Yanting Zhang, Chaoran Chen, Huiyang Liu, Yihan Yang, Honggang Wang. The role of NLRP3 inflammasome in hepatocellular carcinoma. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1150325
153
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al-Hetty, Pushpamala Ramaiah, Alaa Hameed Fazaa, Abduladheem Turki Jalil, Fahad Alsaikhan, Jitendra Gupta, Andrés Alexis Ramírez-Coronel, Nahla A. Tayyib, Hu Peng. Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint. Environmental Research 2023; 227: 115683 doi: 10.1016/j.envres.2023.115683
154
Xuewen Tao, Shuai Mao, Jincheng Wang, Guoqiang Li, Beicheng Sun. Causal Effects and Immune Cell Mediators of Prescription Analgesic Use and Risk of Liver Cancer and Precancerosis in European Population: A Mendelian Randomization Study. Biomedicines 2024; 12(7): 1537 doi: 10.3390/biomedicines12071537
155
Yang Yang, Qi Mei. Accumulation of AGO2 Facilitates Tumorigenesis of Human Hepatocellular Carcinoma. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1631843
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345